Search

Hollyn Franklin (Virginia Tech) and colleagues published a new paper on a phage-conditional mouse model, showing acriflavine can deplete gut phages without significantly impacting bacteria, allowing study of phage impacts in conventionally

Mahshid Khazani Asforooshan (Alzahra University, Iran) and colleagues have isolated and characterized a novel phage targeting Enterococcus faecium from hospital sewage. They designed a hydrogel-based drug delivery carrier, and showed the ph

Yangjing Xiong (Shanghai Jiao Tong University) and colleagues published a new paper on phage therapy for ETEC-induced diarrhea, showing phage JE01 reduced ETEC colonization and inflammation in mice, with fluorescent imaging revealing rapid

Huijun Geng (Dalian University of Technology, China) and colleagues published a paper looking into phage therapy as a treatment for Staphylococcus aureus-induced mastitis using a mouse model. Mice with induced mastitis showed improved masti

Legesse Garedew Kifelew (Flinders University, Australia) and colleagues published a new paper in BMC Microbiology showing efficacy of a cGMP-produced phage cocktail in treating diabetic mouse wound infections caused by MRSA. They applied th

Johanna Sweere (Stanford University) and colleagues developed a mouse model of chronic Pseudomonas wound infection that does not rely on impaired immunity and lasts 10 days without causing sepsis/excessive morbidity. Advances in Wound Care

Johanna Sweere (Stanford University) and colleagues developed a mouse model of chronic Pseudomonas wound infection that does not rely on impaired immunity and lasts 10 days without causing sepsis/excessive morbidity. Advances in Wound Care

This project is aimed at evaluating the use of bacteriophage to treat Staphyloccocus aureus colonization and/or disease in order to better combat multi-antibiotic-resistant bacterial pathogens. A major goal of this project is to establish a

This project is aimed at evaluating the use of bacteriophage to treat Staphyloccocus aureus colonization and/or disease in order to better combat multi-antibiotic-resistant bacterial pathogens. A major goal of this project is to establish a

Marta Lourenço (Institut Pasteur) and colleagues have published a preprint on how inaccessible sites in the mouse gut mucosa serve as a spatial refuge for bacteria, limiting phage predation, and leading to phage-bacterial coexistence that i

Marta Lourenço (Institut Pasteur) and colleagues have published a preprint on how inaccessible sites in the mouse gut mucosa serve as a spatial refuge for bacteria, limiting phage predation, and leading to phage-bacterial coexistence that i

Dr. Kübra Can I am seeking a research position in phage therapy or moleculer phage studies. I hold a PhD from Istanbul University (Institute of Health Sciences, Medical Microbiology Department). I have strong experience in clinical microbi

Dr. Kübra Can I am seeking a research position in phage therapy or moleculer phage studies. I hold a PhD from Istanbul University (Institute of Health Sciences, Medical Microbiology Department). I have strong experience in clinical microbi

Paris, France We are looking for passionate and driven scientists with expertise in testing phage treatments in animals to join our international and highly motivated team in Paris working on engineered phages and CRISPR phages. The ideal c

Paris, France We are looking for passionate and driven scientists with expertise in testing phage treatments in animals to join our international and highly motivated team in Paris working on engineered phages and CRISPR phages. The ideal c

Silver Spring, MD ICON Government and Public Health Solutions specializes in preclinical through phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. The candidate would perform research on ba

Silver Spring, MD ICON Government and Public Health Solutions specializes in preclinical through phase IV support of clinical research and clinical trial services for biologics, drugs, and devices. The candidate would perform research on ba

Marco Cafora and colleagues have developed a zebrafish model of cystic fibrosis and used it to show that phage therapy can treat Pseudomonas aeruginosa (and modulate immune response in the fish). This is the first time that phage therapy ha

Marco Cafora and colleagues have developed a zebrafish model of cystic fibrosis and used it to show that phage therapy can treat Pseudomonas aeruginosa (and modulate immune response in the fish). This is the first time that phage therapy ha